Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 18,000 shares at $29.72 ($535K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Open-market sale of $535k ALKS by EVP R&D, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.72 | 9,000 | $267K | 50.0% |
| 2 | $29.72 | 9,000 | $267K | 50.0% |
| Total | $29.72 avg | 18,000 | $535K | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |